Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
LumiraDx Ltd | LMDX | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,016 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
05/1/2024 | 23:45 | GLOBE | LumiraDx Announces its Securities will be Suspended from.. |
29/12/2023 | 23:07 | DJN | LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche |
29/12/2023 | 22:15 | GLOBE | LumiraDx Announces Agreement to Sell its Cutting Edge Point.. |
27/10/2023 | 22:45 | GLOBE | LumiraDx Announces Receipt of NASDAQ Delisting.. |
21/10/2023 | 00:34 | GLOBE | LumiraDx Partners with AstraZeneca & Everton in the.. |
24/8/2023 | 13:45 | GLOBE | LumiraDx Reports Second Quarter 2023 Results |
16/8/2023 | 22:30 | GLOBE | LumiraDx to Announce Second Quarter Financial Results and.. |
31/7/2023 | 12:00 | GLOBE | LumiraDx’s Point of Care Diagnostics Group Continues.. |
30/6/2023 | 21:26 | DJN | LumiraDx Submits Dual FDA Medical Device Application for.. |
30/6/2023 | 20:30 | GLOBE | LumiraDx Submits First 510(k) Application to the FDA for.. |
20/6/2023 | 22:15 | GLOBE | LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID.. |
16/5/2023 | 13:45 | GLOBE | LumiraDx Reports First Quarter 2023 Results |
09/5/2023 | 22:15 | GLOBE | LumiraDx to Announce First Quarter Financial Results and.. |